Illumina, Inc. is a developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. Using proprietary technologies, Illumina provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, epigenetics, and gene expression profiling, among other applications. These technologies serve as vital tools for disease research, drug development, and the development of molecular tests in the clinical setting.Illumina's products are used by a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the world. With a strong commitment to improving human health, Illumina's technology is intended to accelerate the understanding of genetics and enhance the ability to diagnose, treat, and prevent diseases.